SCHEMBL23597240

SCHEMBL23597240

Clc1ccc(Br)c2oc3c4ccccc4ccc3c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 10/20 0.43
▸ CYP1A1 P04798 9/20 0.43
▸ CYP1B1 Q16678 9/20 0.43
▸ CYP2A6 P11509 2/20 0.43
▸ MAPT P10636 3/20 0.40
▸ HTT P42858 2/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ IKBKB O14920 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.38
▸ HPGD P15428 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ABCB1 P08183 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30133063 1.00 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL23597466 0.89 CYP1A1 (0.43) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL22315500 0.84 CYP1A2 (0.43) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL30133069 0.81 CYP1A1 (0.46) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL23168847 0.81 CYP1A1 (0.46) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL24029286 0.80 CYP1A1 (0.49) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL24048566 0.80 CYP1A1 (0.42) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL24047527 0.79 CYP1A1 (0.43) CYP1A2CYP1A1CYP1B1CYP2A6MAPT
SCHEMBL22315997 0.78 CDC14B (0.51) CYP1A2CYP2A6MAPTKMT2AKDM4E
SCHEMBL30394680 0.78 CDC14B (0.51) CYP1A2CYP2A6MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2024-01-25 — — US disclosed
WO-2022260236-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2022-12-15 — — WO disclosed
WO-2021132984-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DIODE 엘티소재주식회사 2021-07-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025872-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1B1, CYP1A1 CYP1A2 7/4885CYP1A1 3/4885CYP1B1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback